Comparing the current results to its competitors, Venus Concept Inc reported Revenue decrease in the 3 quarter 2025 year on year by -10.11 %, despite the revenue increase by the most of its competitors of 18.57 %, recorded in the same quarter.
Venus Concept Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 32.83 %
Venus Concept Inc 's Comment on Competition and Industry Peers
The medical technology and aesthetic product markets are competitive and rapidly evolving, driven by technological advancements and product innovation. Demand for the company's systems is affected by competing products and procedures. The company's systems compete with conventional non-energy-based treatments, including neurotoxins, dermal fillers, chemical peels, and microdermabrasion. In the United States, competition includes companies offering minimally invasive and non-invasive medical aesthetic procedures. Outside the United States, a wider range of aesthetic products and procedures is available due to less stringent regulatory requirements, allowing competitors to make broader claims about their products' effectiveness.
June 17, 2024
Venus Concept Inc., a leading global medical aesthetic technology company, has recently announced an exclusive strategic supply arrangement with Skin Laundry Holdings, Inc. Under this collaboration, Skin Laundry will be integrating Venus Concept s advanced resurfacing and skin tightening device, Venus Viva, across its chain of clinics in the United States. This partnership will enable Skin Laundry to offer thousands of skin resurfacing treatments per month, leveraging Venus Concepts proprietary (MP)2 NanoFractional RF Technology with SmartScan. With over 9,000 systems installed worldwide, Venus Concepts has established itself as a trusted leader in the field.Key Facts:1. Strategic Supply Arrangement: Skin L...
March 12, 2024
In today s rapidly evolving world, advancements in technology have revolutionized the field of medical aesthetics. Venus Concept recognizes the importance of staying up-to-date with these advancements and ensuring that their customers are equipped with the necessary knowledge and skills to provide the best possible treatments for their clients. With the NEXThetics Program and Venus AI Event Series, they aim to bridge the gap between technological innovations and customer education.The Venus AI Event Series aims to take customer education and training to a whole new level by utilizing cutting-edge artificial intelligence technologies. These events will provide an immersive learning experience, combining inter...
January 17, 2024
Venus Concept Launches Venus Prime - A Game-Changing Financing Program for Aesthetic Medical DevicesTORONTO, Jan. 17, 2024 - Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global leader in medical aesthetic technology, has unveiled an innovative financing program called Venus Prime. Aimed at North American customers, this new program replaces the company s legacy subscription offering. With Venus Prime, eligible customers can now access competitive financing rates and enjoy flexible payment options when purchasing Venus Concept s cutting-edge aesthetic medical devices. Furthermore, customers will have the opportunity for seamless technology upgrades in the second and third years of owner...
December 18, 2023
Venus Concept Expands Global Reach with New Distributors in the UK and India Toronto, Dec. 18, 2023 - Venus Concept Inc. (NASDAQ: VERO), a global leader in medical aesthetic technology, has announced the signing of two exclusive partnerships with Core Aesthetics Skin and Laser Limited in the United Kingdom and Spectra Medical Systems in India. With both regions identified as high-growth markets, these agreements are a significant move towards Venus Concept s goal of driving international expansion through strong distributor partnerships. The expansion of Venus Concept s international distributor network reflects the company s commitment to meeting the increasing demands for its innovative medical aes...
Iridex Corp's business model revolves around providing advanced medical devices and solutions for the treatment of eye conditions, primarily focused on ophthalmology.
Inmode Ltd is a medical technology company that specializes in developing and commercializing minimally invasive aesthetic and medical solutions. They primarily operate on a direct-to-consumer model, selling their devices to physicians, medical spas, and clinics. In addition to device sales, they generate recurring revenue through consumable product sales and service contracts for their devices.
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
Guided Therapeutics Inc operates on a business model focused on developing and commercializing medical devices for the early detection and monitoring of diseases, with a particular emphasis on cervical cancer.
Sources:
Venus Concept Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Venus Concept Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
